Literature DB >> 3893608

Antirheumatic medication during lactation.

C J Needs, P M Brooks.   

Abstract

All nonsteroidal anti-inflammatory drugs (NSAIDs) and antirheumatic drugs are likely to be distributed into human milk to some extent; whether they are detected is a function of the assay sensitivity. For minimal infant exposure, the ideal drug for lactating women is one which has a short half-life, is found in minimal quantities in human milk and has inactive metabolites which also are present only in small amounts. In order to reduce the quantity of drug presented to the child, the drug should be taken by the mother at the time of breast-feeding with the next feed occurring after a time period equivalent to one half-life of the drug. Using the above-mentioned criteria, the choice of NSAIDs would be between a short half-life propionic acid derivative, with little biotransformation, such as ibuprofen or flurbiprofen. Diclofenac is also suitable. Gold salts and corticosteroids would seem safe to prescribe. However, the infant should be closely monitored if antimalarials are being used by lactating women.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893608     DOI: 10.1093/rheumatology/24.3.291

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  14 in total

Review 1.  Analgesics and breast-feeding: safety considerations.

Authors:  O Spigset; S Hägg
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  [Anesthesia in the breast feeding period. Excretion of anesthetic agents and adjuvants into breast milk and potential pharmacological side-effects on the suckling infant].

Authors:  C Lang; G Geldner; H Wulf
Journal:  Anaesthesist       Date:  2003-10       Impact factor: 1.041

3.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Treatment of rheumatic diseases.

Authors:  M A Byron
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-24

5.  Prescribing in pregnancy. General principles.

Authors:  P C Rubin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

Review 6.  Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.

Authors:  Bruce I Gaynes; Richard Fiscella
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Excretion of indomethacin in breast milk.

Authors:  T H Lebedevs; R E Wojnar-Horton; P Yapp; M J Roberts; L J Dusci; L P Hackett; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

8.  Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects.

Authors:  I Matheson; P K Lunde; J E Bredesen
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 9.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

10.  Serum salicylate levels in a breast fed infant.

Authors:  J Unsworth; A d'Assis-Fonseca; D T Beswick; D R Blake
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.